Parallel has appointed Walgreens veteran Jeremy Kunicki as its chief financial officer, effective immediately.
Parallel announced last week that it intends to become a public company through a definitive business combination agreement with Ceres Acquisition Corp., a special purpose acquisition corporation (SPAC). As CFO, Kunicki will lead Parallel's finance and operations functions, as well as oversee corporate finance, shared services activities and operational management of the organization.
James Whitcomb, who had served as Parallel's interim CFO, will continue in his role as chief development officer.
"I am excited to join Parallel as it prepares to become a publicly traded company,” Kunicki said. “In a few short years, Parallel has differentiated itself as a leader in the cannabis industry, with strong revenue growth, an exceptional and seasoned leadership team, and a customer, community, and employee-centric vision. I look forward to working with the Parallel team to pioneer consumer and patient well-being through the benefits of cannabinoids."
Kunicki joins Parallel from Walgreens Boots Alliance, Inc., where he most recently served as CFO for the Walgreens division, one of the largest retail pharmacy companies in the United States. In this position, Kunicki led Walgreens' finance team for the U.S. business and was responsible for financial oversight of investments, financial planning, performance management and business development.
Throughout his 20 years at Walgreens, Kunicki filled various finance leadership roles with a specific focus on operations, supply chain, real estate, digital and IT. Kunicki has also led company-wide cost transformation programs and oversaw finance for M&A integrations. Kunicki holds a Master of Accountancy from the University of Wisconsin-Madison.
"We are thrilled to welcome Jeremy to Parallel's executive leadership team, especially at this momentous time for our company,” said William "Beau'' Wrigley, Jr., CEO and chairman of Parallel. “Jeremy's expertise in translating strategy into tangible corporate initiatives that drive growth will be a vital asset as Parallel continues to scale as a national cannabis well-being company. Most importantly, his community-focused values, passion for prioritizing consumer health and track record of building high performance teams align perfectly with our culture.”